Fact · Accessibility and health
A 2023 Cochrane review found that splinting may give little or no symptom benefit in the first three months.
Checked against its source on October 16, 2026
In the source's own words
“splinting may provide little or no benefits in symptoms in the short term (< 3 months)”
Splinting for carpal tunnel syndrome, TV Karjalainen et al., Cochrane Database of Systematic Reviews, 2023, Main results.
Open the original (DOI 10.1002/14651858.CD010003.pub2)- What it measures
- The primary comparison was splinting against no active treatment.
- What it does not show
- Certainty of evidence is low, and the trials were generally at high risk of bias, mostly because they were not blinded.